Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Funding Opportunity Announcements

Partnerships for Environmental Public Health (PEPH)

bar graph being viewed through magnifying glass

As a network, PEPH highlights funding opportunity announcements from NIEHS, from other institutes and centers (ICs) at the National Institutes of Health (NIH) and from other Federal partners. This section lists and describes the various funding opportunity announcements that are PEPH-related. This list will change as new funding opportunity announcements are released and others close.

NIEHS encourages investigators to submit project applications using the unsolicited research grant process (e.g., R01s). Unsolicited, investigator-initiated proposals are sent to NIH for review at the Center for Scientific Review (CSR). There are many Integrated Review Groups (IRGs) at CSR; however, those most likely to be appropriate for PEPH-related unsolicited applications include the Population Sciences and Epidemiology IRG and the Healthcare Delivery and Methodologies IRG.

When preparing your proposal, we highly encourage you to do the following:

Current Available Funding Opportunities

Application Due Date May 17 2022
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

Supports research on interventions to improve health in Native American populations. This includes 1) etiologic research, where there is a significant gap in knowledge that will directly inform intervention development or adaptations, 2) research that develops, adapts, or tests the efficacy or effectiveness of health promotion and disease prevention interventions, 3) research that tests culturally informed treatment or recovery interventions, and 4) where a sufficient body of knowledge on intervention efficacy exists, research on dissemination and implementation that develops and tests strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions. Through this initiative, intervention and related research is sought to build upon community knowledge, resources, and resilience to test science-based, culturally appropriate solutions to reduce morbidity and mortality through identification and remediation of precursors to diseases and disorders and through culturally informed treatment.

Deadlines: May 17, 2022; May 17, 2023

Letter of Intent: Due 30 days prior to the application due date

Application Due Date May 23 2022
Limited Competition: Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Optional)

Supports collaborative investigative teams or individual scientists who propose unusually innovative research projects, which, if successful, would have a major impact in developing, implementing, or disseminating innovative and effective interventions to prevent, reduce, or eliminate health disparities and advance health equity. No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact in addressing health disparities and advancing health equity. Applicants are encouraged to carefully review the Answers to Frequently Asked Questions and view slides from a pre-recorded pre-application webinar to help prepare an application for this FOA. Additionally, an upcoming pre-application technical assistance webinar will take place on April 13, 2022. Registration is open.

Deadline: May 23, 2022

Application Due Date May 26 2022
Support for Research Excellence Award (R16 Clinical Trial Not Allowed)

The purpose of Support for Research Excellence (SuRE) awards is to provide research grant support for faculty investigators who have prior experience in leading externally funded, independent research but are not currently funded by any NIH Research Project Grants with the exception of SuRE or SuRE-First awards. Awards are open to institutions that receive no more than $6 million per year from NIH Research Project Grants and additionally enroll at least 25 percent of undergraduate students supported by Pell grants or are an accredited medical/health professional school with a historical mission statement that explicitly states that it was founded to educate students from nationally underrepresented backgrounds.

Deadlines: May 26, 2022; May 26, 2023

Application Due Date Jun 05 2022
Accelerating the Pace of Child Health Research Using Existing Data From the Adolescent Brain Cognitive Development (ABCD) Study (R01-clinical Trial Not Allowed)

Supports activities proposing to conduct analyses of existing ABCD Study data to accelerate the pace of research on child health and development, including: cross-sectional and/or longitudinal analyses; development of new or advanced statistical methods; and/or integration of ABCD data with other existing datasets that share common data elements. NIEHS is interested in applications that will use ABCD data resources to examine the contribution of environmental exposures on brain and development and to identify sensitive time windows of development that may confer individual susceptibility and also to identify protective factors that may mitigate environmental-induced changes. An R21 funding opportunity is also open.

Deadlines: June 5, 2022; October 5, 2022; February 5, 2023

Application Due Date Jun 05 2022
Notice of Special Interest (NOSI): Emerging and Existing Issues of Coronavirus Disease 2019 (COVID-19) Research Related to the Health and Well-being of Women, Children and Individuals With Physical And/Or Intellectual Disabilities

Provides an avenue for researchers to pursue funding to conduct research addressing emerging and existing COVID-related issues among pregnant and lactating people, infants, children and adolescents, and individuals with physical and/or intellectual disabilities. NIEHS is interested in research focused on better understanding the role of environmental exposures on the multitude of factors surrounding the COVID-19 pandemic in relation to pregnancy, children and adolescent health and well-being, reproductive disorders, metabolic diseases, cancers, cardiovascular disease, and other disease conditions. Applicants responding to this NOSI are strongly encouraged to describe plans for the rapid sharing of data and results as well as innovative data analytics approaches. The sharing of COVID-related data and resources and effective communication of results are a high priority of the NIH.

Deadline: June 5, 2022

Application Due Date Jun 05 2022
Notice of Special Interest (NOSI): Epidemiologic Studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed)

Encourages fundamental epidemiological research geared toward understanding the inter-relationships of biological, lifestyle/behavioral, environmental, and sociocultural factors and how these factors may impact health disparities and outcomes in Asian American, Native Hawaiian, and Pacific Islander subpopulations. Epidemiological inference is enhanced with variation in study designs; therefore, investigators may leverage a range of design methods in response to this NOSI, including electronic health record databases, registries, cohort studies, and cross-sectional surveys. Applications may propose leveraging existing studies or data, or may propose new data collection. To be considered responsive to this NOSI, applicants must propose to study at least one specific subpopulation of Asian Americans, Native Hawaiians, and Pacific Islanders. NIEHS applications to this funding opportunity occur through Research Project Grant (Parent R01 Clinical Trial Not Allowed), Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical Trial Not Allowed), and The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional).

Deadline:  June 5, 2022

Application Due Date Jun 06 2022
Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and Their Communities

Supports partnerships between Worker Training Program (WTP) recipients and local community organizations in communities highly impacted by COVID-19 to increase the education and awareness of COVID-19 health risks and promote the integration and connectedness to needed public health resources such as testing, contact tracing, and the adoption of effective infection control measures. This NOSI is open to current WTP awardees who already have partnerships with local worker centers and community organizations in underserved and disadvantaged communities with COVID-19 transmission rates that are higher than the national average. Partnerships with other NIEHS recipients are encouraged if the collaboration will meet the aims of the application.

Deadline: June 6, 2022

Application Due Date Jun 09 2022
Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional)

The RIVER program is intended to invest in people rather than projects; rewarding individuals from the NIEHS recipient community who demonstrate a broad vision and potential for continuing their impactful environmental health research and who are most likely to benefit from a program emphasizing flexibility and sustained support. Only single principal investigator applications are allowed. Key features and benefits of the program fall into two large categories: 1) freedom from traditional focused specific aims and a structured research plan which will enable investigators to pursue new directions in their research as they arise throughout the funding period, and 2) the ability to devote increased effort to research, mentoring, and scientific service due to reduced time spent writing and managing multiple grant applications and awards.

Deadline: June 9, 2022

Letter of Intent: Due 30 days prior to the application due date

Application Due Date Jun 24 2022
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)

The Lasker Clinical Research Scholars program will offer applicants the opportunity to compete for a unique combination of intramural and extramural resources for clinical research. The program will support a small number of exceptional clinical researchers in the early stages of their independent careers to promote their development as fully independent scientists. The program combines a period of research experience as a tenure-track investigator in the Intramural Research Program with additional years of independent financial support, either within the Intramural Research Program or at an extramural research institution. Successful applicants will receive support in two phases: 1) support for scholars in the Intramural Research Program for up to 5 years, with the possibility of an extension for an additional 2 years; and 2) either continued Intramural Research Program support, or up to 3 years of support to continue research as an independent clinician scientist at an extramural institution.

Deadline: June 24, 2022

Application Due Date Jun 25 2022
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

The REAP program will enable qualified scientists to receive support for small-scale research projects. It is anticipated that investigators supported under the REAP program will benefit from the opportunity to conduct independent research; that the grantee institution will benefit from a research environment strengthened through REAP grants; and that students at recipient institutions will benefit from exposure to and participation in scientific research in the biomedical sciences so that they consider careers in biomedical research. The REAP funding opportunity emphasizes the engagement and inclusion of health professional, undergraduates, and/or graduate students in research. Since diversity strengthens the research environment, REAP grantees are encouraged to recruit and include students from diverse backgrounds, including those from groups underrepresented in the biomedical research workforce. NIEHS will accept applications describing research projects that will have a defined impact on the environmental health sciences and must have a research focus on exposure-health related responses from environmental agents within the mission interest of the NIEHS.

Deadlines: June 25, 2022; October 25, 2022

Application Due Date Jul 27 2022
Implementation Research to Reduce Noncommunicable Disease Burden in Low- and Middle-income Countries and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional)

Supports innovative approaches to identifying, understanding, developing, and implementing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines. In addition, studies to advance dissemination and implementation research methods and measures into application are encouraged. Specifically, this FOA invites applications that propose interventions targeting critical life stages (e.g., infancy, childhood, adolescence, pregnancy, older adults) and key transitions between life stages to reduce health risk and/or enhance positive health and lifestyle behaviors. NIEHS is interested in applications that focus on the implementation of interventions that address environmental noncommunicable disease risk factors (e.g., air pollution, disaster risks attributed to climate change, etc.) in one or more critical life stages.

Deadline: July 27, 2022

Back
to Top